-
Nutlin-3a MDM2 Inhibitor Workflows for Cancer Research
2026-09-14
Build reproducible Nutlin-3a experiments around p53 stabilization, cell-cycle profiling, and apoptosis induction rather than relying on a single viability endpoint. The workflow also shows how to use this MDM2 inhibitor as a controlled perturbation alongside the miR-18a/ALOXE3 biology reported in glioblastoma research.
-
From T7 Transcription to Translational RNA Design
2026-09-13
A mechanistic and strategic guide to using defined T7-generated RNA as a foundation for epitranscriptomic studies, assay validation, RNA vaccine research, and translational decision-making.
-
Sodium Picosulfate Research Workflows
2026-09-12
Sodium Picosulfate offers a practical, controllable perturbation for intestinal transit, electrolyte handling, and liver-cell response studies. This guide connects bench assays with gut–liver–brain research while clearly separating established product characteristics from exploratory applications.
-
Dual Luciferase Reporter Gene System in ICC
2026-09-11
Use the Dual Luciferase Reporter Gene System to test enhancer activity, transcription-factor effects, and normalization-sensitive gene expression changes in mammalian cells. This workflow translates the ZNF263–ULK1 findings in intrahepatic cholangiocarcinoma into practical reporter experiments while adding troubleshooting guidance for scalable assays.
-
Sorafenib as a Time-Resolved Host-Directed Tool
2026-09-11
Sorafenib (BAY-43-9006) is more than a multikinase inhibitor: it can anchor experiments that connect RAF/MEK/ERK signaling, angiogenesis, and temporally resolved host responses. This article translates emerging EBOV transcriptomics into practical assay decisions while preserving Sorafenib’s value in oncology models.
-
JZL184: MAGL Inhibitor Workflows for Pain
2026-09-10
JZL184 gives researchers a direct way to elevate 2-AG and interrogate MAGL-dependent endocannabinoid signaling across synaptic, biochemical, and behavioral assays. This guide translates that mechanism into practical workflows for pain, affective-state, and CB1-linked neuroscience studies while emphasizing formulation control and orthogonal validation.
-
Simvastatin (Zocor): From Lipid Biology to Phenotypes
2026-09-09
Simvastatin (Zocor) is more than a cholesterol synthesis inhibitor: it is a useful probe for connecting HMG-CoA reductase biology with cell-state phenotypes. This article shows how machine-learning-aware assay design can distinguish mechanism, cellular context, and nonspecific toxicity.
-
Estrogen–Autophagy Axis in Perimenopausal Aging
2026-09-09
A 2026 study integrates NHANES data, perimenopausal mouse experiments, network pharmacology, and inhibitor-based validation to examine how estrogen protects the heart, aorta, and kidneys. Its central contribution is linking estradiol deficiency with multi-organ fibrosis through receptor-dependent autophagy signaling, while also defining important considerations for interpreting pharmacologic autophagy inhibition.
-
Phebestin: Nanomolar Aminopeptidase Inhibitor in Malaria
2026-09-08
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial compound active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its integrated parasite-stage, washout, computational, and mouse studies provide a useful framework for evaluating aminopeptidases as malaria drug targets while also defining important limits for translation.
-
Gentamycin Sulfate: Reliable Assay Workflows
2026-09-08
Learn how Gentamycin Sulfate, SKU A2514, can support controlled bacterial protein synthesis research, Gram-negative infection models, and antibiotic-resistance experiments without obscuring cell-viability results. The article connects product specifications with practical assay controls and recent evidence on carbapenem-resistant Enterobacter cloacae.
-
Phebestin: A Bestatin-Related Antiplasmodial Lead
2026-09-07
The reference study identifies phebestin as a nanomolar antiplasmodial compound active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. By combining parasite-stage assays, washout experiments, molecular modeling, and mouse infection studies, the authors connect phebestin activity with parasite aminopeptidases while defining important limits for further validation.
-
Nitrocefin: From Color Change to Resistance Insight
2026-09-07
Nitrocefin is a chromogenic cephalosporin substrate that converts β-lactamase hydrolysis into a measurable color signal. This guide explains how to interpret that signal alongside enzyme mechanism, inhibitor performance, and antibiotic resistance phenotypes.
-
Prolonged Hypoxia Activates NLRP3 in Urothelium
2026-09-05
Hudson and colleagues show that enzyme-induced hypoxia produces a duration-dependent response in rat urothelial cells: brief exposure triggers hypoxic adaptation, whereas prolonged exposure increases caspase-1 activity through a ROS/TXNIP/NLRP3-linked mechanism. The study helps distinguish reversible tissue stress from inflammation relevant to bladder outlet obstruction and provides a framework for interpreting antioxidant and pathway-inhibitor experiments.
-
Dihydroartemisinin: From Mechanism to Translation
2026-09-04
Dihydroartemisinin is more than an antimalarial research reagent: it is a defined Artemisia-derived scaffold for connecting parasite biology, mTOR-linked proliferation, and inflammation research. This thought-leadership guide shows how to position the compound against mechanistically distinct antiplasmodial strategies, build reproducible assays, and avoid overextending preclinical evidence.
-
Betaine Hydrochloride: Research Uses and Limits
2026-09-04
Betaine hydrochloride is a water-soluble quaternary ammonium salt used as a reagent in biochemical and molecular biology workflows. Its documented value is strongest for controlled solution preparation, metabolic enzyme research, and protease assay development; the cited esophageal-cancer study concerns oridonin rather than betaine hydrochloride.